title: Te Mata Ono. E tipu atu te kūmara, e ohu mai te anuhe

authors: Pēwhairangi, Te Aorere Tūwhakairiora

subjects: Māori television

abstract: Mai anō, mai anō kua whakapaoho te iwi Māori, tīmata mai ai i te mahi whaikōrero, i te mahi karanga, i te mahi taonga puoro, i te mahi toi, me te mahi waiata. Ko ngā mahi nei he huarahi tuku karere i tētahi takitahi, takitini rānei ki tētahi takitahi, takitini rānei. Mā ēnei mahi e whakawhitiwhiti mōhiohio ai te tangata. Nō te taitanga mai a te Pākehā kua whai huarahi whakapaoho atu anō te iwi Māori i ō rātau mōhiohio, tīmata ana mai i ngā niu pepa, eke ana rā ki ngā reo irirangi, tae noa mai ki te pouaka whakaata me te ipurangi. Ko te rangahautanga nei ka titiro ki tētahi o ngā huarahi mātāmuri e whakapaohotia ai ngā mōhiohio a te Māori, arā te pouaka whakaata. Ka arotaketia ngā mahi tuari mōhiohio a te whare waihanga hōtaka pouaka whakaata nei a Whakaata Māori mā tētahi anga tātai e kīia nei ko Te Mata Ono.

I ngā tau 15 kua pahure ake nei ehara i te mea kua tū a Whakaata Māori hai kaitohatoha mōhiohio Māori, engari hai kaiwhakarauora hoki i te reo Māori me ngā tikanga Māori. I te tuhinga roa nei ka tirohia ngā huarahi taketake me ngā huarahi hōu o te whakapaoho i ngā mōhiohio o te tangata mā roto i a Whakaata Māori. Mā te whakauruuru i ngā huarahi e rua nei e whakahōuhia ai te ara, e whakapaoho Māoritia ai hoki ngā hōtaka o te wā. 

E ono katoa ngā āhuatanga o te anga e kōrerotia nei. Ko te tuhinga roa nei he haurua o te anga. Nā ngā ture ā-kupu o te tohu paerua nei, ka rangahaua rētōtia e a au ngā wāhanga e toru o te ono e kīia nei ko Te Mata Ako, Te Mata Tikanga, Te Mata Iwi anō hoki. E tuhia ana hoki tētahi atu tuhinga roa i te wā nei e Kimiora Kaire-Melbourne. Kai te titiro ia ki ērā atu wāhanga e toru o te anga, Te Mata Māori, Te Mata Pākehā me Te Mata ō-Tua. Hai te mutunga o ngā tuhinga roa e rua nei, ka whakapiria ai ngā āhuatanga e ono kia waihanga pūmautia ai te anga tātari o Te Mata Ono. Ka piri ana te anga tātari ko te whāinga kia whakahāngaitia ai ki a Whakaata Māori hai tautoko, hai hāpai, hai ārahi hoki i te teihanga ki ngā rā kai te heke mai.

text: Te Mata Ono. E tipu atu te kūmara, e ohu mai te anuhe Mai anō, mai anō kua whakapaoho te iwi Māori, tīmata mai ai i te mahi whaikōrero, i te mahi karanga, i te mahi taonga puoro, i te mahi toi, me te mahi waiata. Ko ngā mahi nei he huarahi tuku karere i tētahi takitahi, takitini rānei ki tētahi takitahi, takitini rānei. Mā ēnei mahi e whakawhitiwhiti mōhiohio ai te tangata. Nō te taitanga mai a te Pākehā kua whai huarahi whakapaoho atu anō te iwi Māori i ō rātau mōhiohio, tīmata ana mai i ngā niu pepa, eke ana rā ki ngā reo irirangi, tae noa mai ki te pouaka whakaata me te ipurangi. Ko te rangahautanga nei ka titiro ki tētahi o ngā huarahi mātāmuri e whakapaohotia ai ngā mōhiohio a te Māori, arā te pouaka whakaata. Ka arotaketia ngā mahi tuari mōhiohio a te whare waihanga hōtaka pouaka whakaata nei a Whakaata Māori mā tētahi anga tātai e kīia nei ko Te Mata Ono.

I ngā tau 15 kua pahure ake nei ehara i te mea kua tū a Whakaata Māori hai kaitohatoha mōhiohio Māori, engari hai kaiwhakarauora hoki i te reo Māori me ngā tikanga Māori. I te tuhinga roa nei ka tirohia ngā huarahi taketake me ngā huarahi hōu o te whakapaoho i ngā mōhiohio o te tangata mā roto i a Whakaata Māori. Mā te whakauruuru i ngā huarahi e rua nei e whakahōuhia ai te ara, e whakapaoho Māoritia ai hoki ngā hōtaka o te wā. 

E ono katoa ngā āhuatanga o te anga e kōrerotia nei. Ko te tuhinga roa nei he haurua o te anga. Nā ngā ture ā-kupu o te tohu paerua nei, ka rangahaua rētōtia e a au ngā wāhanga e toru o te ono e kīia nei ko Te Mata Ako, Te Mata Tikanga, Te Mata Iwi anō hoki. E tuhia ana hoki tētahi atu tuhinga roa i te wā nei e Kimiora Kaire-Melbourne. Kai te titiro ia ki ērā atu wāhanga e toru o te anga, Te Mata Māori, Te Mata Pākehā me Te Mata ō-Tua. Hai te mutunga o ngā tuhinga roa e rua nei, ka whakapiria ai ngā āhuatanga e ono kia waihanga pūmautia ai te anga tātari o Te Mata Ono. Ka piri ana te anga tātari ko te whāinga kia whakahāngaitia ai ki a Whakaata Māori hai tautoko, hai hāpai, hai ārahi hoki i te teihanga ki ngā rā kai te heke mai.

year: 2019

title: Waitomo District: Demographic profile 1986-2031

authors: Jackson, Natalie

abstract: This report outlines the demographic changes that have occurred in Waitomo Region, as well as what trends are expected in the future.

text: Waitomo District: Demographic profile 1986-2031 This report outlines the demographic changes that have occurred in Waitomo Region, as well as what trends are expected in the future.

year: 2014

title: Developing a core outcome set for future infertility research: an international consensus development study

authors: Duffy, J.M.N.

subjects: Consensus development study

abstract: STUDY QUESTION: Can a core outcome set to standardize outcome selection, collection and reporting across future infertility research be developed? 
SUMMARY ANSWER: A minimum data set, known as a core outcome set, has been developed for randomized controlled trials (RCTs) and systematic reviews evaluating potential treatments for infertility. 
WHAT IS KNOWN ALREADY: Complex issues, including a failure to consider the perspectives of people with fertility problems when selecting outcomes, variations in outcome definitions and the selective reporting of outcomes on the basis of statistical analysis, make the results of infertility research difficult to interpret. 
STUDY DESIGN, SIZE, DURATION: A three-round Delphi survey (372 participants from 41 countries) and consensus development workshop (30 participants from 27 countries). PARTICIPANTS/MATERIALS, SETTING, METHODS: Healthcare professionals, researchers and people with fertility problems were brought together in an open and transparent process using formal consensus science methods. 
MAIN RESULTS AND THE ROLE OF CHANCE: The core outcome set consists of: viable intrauterine pregnancy confirmed by ultrasound (accounting for singleton, twin and higher multiple pregnancy); pregnancy loss (accounting for ectopic pregnancy, miscarriage, stillbirth and termination of pregnancy); live birth; gestational age at delivery; birthweight; neonatal mortality; and major congenital anomaly. Time to pregnancy leading to live birth should be reported when applicable. 
LIMITATIONS, REASONS FOR CAUTION: We used consensus development methods which have inherent limitations, including the representativeness of the participant sample, Delphi survey attrition and an arbitrary consensus threshold. 
WIDER IMPLICATIONS OF THE FINDINGS: Embedding the core outcome set within RCTs and systematic reviews should ensure the comprehensive selection, collection and reporting of core outcomes. Research funding bodies, the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) statement, and over 80 specialty journals, including the Cochrane Gynaecology and Fertility Group, Fertility and Sterility and Human Reproduction, have committed to implementing this core outcome set. 
STUDY FUNDING/COMPETING INTEREST(S): This research was funded by the Catalyst Fund, Royal Society of New Zealand, Auckland Medical Research Fund and Maurice and Phyllis Paykel Trust. The funder had no role in the design and conduct of the study, the collection, management, analysis or interpretation of data, or manuscript preparation. B.W.J.M. is supported by a National Health and Medical Research Council Practitioner Fellowship (GNT1082548). S.B. was supported by University of Auckland Foundation Seelye Travelling Fellowship. S.B. reports being the Editor-in-Chief of Human Reproduction Open and an editor of the Cochrane Gynaecology and Fertility group. J.L.H.E. reports being the Editor Emeritus of Human Reproduction. J.M.L.K. reports research sponsorship from Ferring and Theramex. R.S.L. reports consultancy fees from Abbvie, Bayer, Ferring, Fractyl, Insud Pharma and Kindex and research sponsorship from Guerbet and Hass Avocado Board. B.W.J.M. reports consultancy fees from Guerbet, iGenomix, Merck, Merck KGaA and ObsEva. C.N. reports being the Co Editor-in-Chief of Fertility and Sterility and Section Editor of the Journal of Urology, research sponsorship from Ferring, and retains a financial interest in NexHand. A.S. reports consultancy fees from Guerbet. E.H.Y.N. reports research sponsorship from Merck. N.L.V. reports consultancy and conference fees from Ferring, Merck and Merck Sharp and Dohme. The remaining authors declare no competing interests in relation to the work presented. All authors have completed the disclosure form. TRIAL REGISTRATION NUMBER: Core Outcome Measures in Effectiveness Trials Initiative: 1023.

text: Developing a core outcome set for future infertility research: an international consensus development study STUDY QUESTION: Can a core outcome set to standardize outcome selection, collection and reporting across future infertility research be developed? 
SUMMARY ANSWER: A minimum data set, known as a core outcome set, has been developed for randomized controlled trials (RCTs) and systematic reviews evaluating potential treatments for infertility. 
WHAT IS KNOWN ALREADY: Complex issues, including a failure to consider the perspectives of people with fertility problems when selecting outcomes, variations in outcome definitions and the selective reporting of outcomes on the basis of statistical analysis, make the results of infertility research difficult to interpret. 
STUDY DESIGN, SIZE, DURATION: A three-round Delphi survey (372 participants from 41 countries) and consensus development workshop (30 participants from 27 countries). PARTICIPANTS/MATERIALS, SETTING, METHODS: Healthcare professionals, researchers and people with fertility problems were brought together in an open and transparent process using formal consensus science methods. 
MAIN RESULTS AND THE ROLE OF CHANCE: The core outcome set consists of: viable intrauterine pregnancy confirmed by ultrasound (accounting for singleton, twin and higher multiple pregnancy); pregnancy loss (accounting for ectopic pregnancy, miscarriage, stillbirth and termination of pregnancy); live birth; gestational age at delivery; birthweight; neonatal mortality; and major congenital anomaly. Time to pregnancy leading to live birth should be reported when applicable. 
LIMITATIONS, REASONS FOR CAUTION: We used consensus development methods which have inherent limitations, including the representativeness of the participant sample, Delphi survey attrition and an arbitrary consensus threshold. 
WIDER IMPLICATIONS OF THE FINDINGS: Embedding the core outcome set within RCTs and systematic reviews should ensure the comprehensive selection, collection and reporting of core outcomes. Research funding bodies, the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) statement, and over 80 specialty journals, including the Cochrane Gynaecology and Fertility Group, Fertility and Sterility and Human Reproduction, have committed to implementing this core outcome set. 
STUDY FUNDING/COMPETING INTEREST(S): This research was funded by the Catalyst Fund, Royal Society of New Zealand, Auckland Medical Research Fund and Maurice and Phyllis Paykel Trust. The funder had no role in the design and conduct of the study, the collection, management, analysis or interpretation of data, or manuscript preparation. B.W.J.M. is supported by a National Health and Medical Research Council Practitioner Fellowship (GNT1082548). S.B. was supported by University of Auckland Foundation Seelye Travelling Fellowship. S.B. reports being the Editor-in-Chief of Human Reproduction Open and an editor of the Cochrane Gynaecology and Fertility group. J.L.H.E. reports being the Editor Emeritus of Human Reproduction. J.M.L.K. reports research sponsorship from Ferring and Theramex. R.S.L. reports consultancy fees from Abbvie, Bayer, Ferring, Fractyl, Insud Pharma and Kindex and research sponsorship from Guerbet and Hass Avocado Board. B.W.J.M. reports consultancy fees from Guerbet, iGenomix, Merck, Merck KGaA and ObsEva. C.N. reports being the Co Editor-in-Chief of Fertility and Sterility and Section Editor of the Journal of Urology, research sponsorship from Ferring, and retains a financial interest in NexHand. A.S. reports consultancy fees from Guerbet. E.H.Y.N. reports research sponsorship from Merck. N.L.V. reports consultancy and conference fees from Ferring, Merck and Merck Sharp and Dohme. The remaining authors declare no competing interests in relation to the work presented. All authors have completed the disclosure form. TRIAL REGISTRATION NUMBER: Core Outcome Measures in Effectiveness Trials Initiative: 1023.

year: 2020